Arbutus Biopharma Corp (ABUS)

SG&A Expense Growth

-34.21%

Quarterly · Period ending:

ABUS logo

ABUS SG&A Expense Growth

Latest reported-34.21%
ABUS Quarterly SG&A Growth (QoQ) (0.00% → -34.21%)
High-resolution chart · PNG

ABUS sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-34.2123%
58.8649%
21.9914%
-8.8642%
-42.9355%
-30.8349%
85.8497%
-39.8834%
42.0745%
4.1364%
-12.684%
-2.3077%
7.7089%
30.666%
21.6433%
-32.8269%
6.296%
6.4172%
9.8972%
-6.5878%
15.4719%
5.9273%
-9.9385%
13.9933%
0.3659%
89.2914%
-42.2284%
-60.3248%
85.6074%
-25.561%
125.2756%
-30.3046%
2.8891%
3.5563%
-3.1703%
-20.4392%
6.2616%
-8.5569%
27.2312%
-84.3474%
229.2146%
-13.5863%
8.409%
0.0779%
183.5052%
-11.8754%
74.7166%
-1.2871%
-12.8293%
-28.0505%
197.1707%
15.4295%
-8.0614%
-95.7123%
1,278.339%
-35.3185%
29.452%
-8.5604%
71.5481%
-29.2997%
3.7888%
19.1384%
-7.3104%
40.0632%
5.0367%
-14.2575%
30.8258%
-9.7445%
25.282%
233.226%
-77.8499%
-41.0539%
167.1641%
-36.971%
29.5895%
-48.0913%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.